宏中药业 (833746.OC)

+ 收藏

财务分析(报告期)(宏中药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 37,221,976.86100,844,903.6475,918,572.1244,595,534.3521,926,690.5297,681,527.78-49,363,364.8723,436,387.05
 营业利润(元) 12,281,857.0541,499,616.1631,378,962.0219,224,195.9610,184,709.3948,935,464.75-23,226,846.5110,074,506.27
 利润总额(元) 12,157,588.4250,025,730.5139,306,357.7123,153,075.4210,114,801.8048,562,771.34-23,232,029.8810,079,689.64
 净利润(元) 10,989,514.6844,546,181.0234,241,155.8220,045,333.638,734,794.6346,802,985.53-23,384,777.8110,079,689.64
 归属于母公司股东的净利润(元) 10,989,514.6844,546,181.0234,241,155.8220,045,333.638,734,794.6346,802,985.53-23,384,777.8110,079,689.64
盈利能力:
 销售毛利率(%) 63.5864.0864.7865.7465.4267.4264.3262.6755.69
 销售净利率(%) 29.5244.1745.1044.9539.8447.9147.3047.3743.01
 净资产收益率(%) 7.9334.27-19.549.39----
 总资产报酬率ROA(%) 6.0729.11-15.597.22----
 投入资本回报率ROIC(%) 6.0330.0422.9114.886.7546.0371.8627.1711.52
营运能力:
 存货周转率(次) 0.321.02-0.470.25----
 应收账款周转率(次) 2.646.10-3.361.85----
 总资产周转率(次) 0.180.58-0.290.15----
偿债能力:
 资产负债率(%) 30.9527.7732.4632.6029.2922.58-34.4345.90
 股东权益比率(%) 69.0572.2367.5467.4070.7177.42-65.5754.10
 已获利息倍数(倍) 77.2058.1544.9828.5524.4873.13-70.1220.42
 流动比率 1.351.471.341.152.772.12-1.391.38
 速动比率 0.560.720.730.401.270.73-0.620.66
发展能力:
 营业收入增长率(%) -16.533.2416.98-9.66-0.2953.28-81.43198.84
 营业利润增长率(%) -36.11-15.202.31-17.231.09128.78-255.071,097.32
 税后利润增长率(%) -45.18-4.8211.54-14.28-13.34117.40-256.861,097.78
 净资产增长率(%) 22.0636.90-55.3577.3892.63-135.57101.18
 总资产增长率(%) 19.1546.74-51.1335.7022.96-6.3910.98

前瞻产业研究院